Hiroaki Ono
6PUBLICATIONS
21CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Aug 06, 2025
Evaluation of therapeutic agent selection based on comprehensive genomic profiling in gastroenteropancreatic neuroendocrine neoplasms.Suguru Miyazawa, Hiroaki Ono, Hironari Yamashita
|Jun 12, 2025
PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer.Kentaro Umemura, Yoshimitsu Akiyama, Shu Shimada
|Oct 22, 2022
Identification of a novel target of SETD1A histone methyltransferase and the clinical significance in pancreatic cancer.Takeshi Ishii, Yoshimitsu Akiyama, Shu Shimada
|Sep 12, 2021
Inhibitor library screening identifies ispinesib as a new potential chemotherapeutic agent for pancreatic cancers.Yoshiki Murase, Hiroaki Ono, Kosuke Ogawa
|Jun 10, 2021
Cytoplasmic RRM1 activation as an acute response to gemcitabine treatment is involved in drug resistance of pancreatic cancer cells.Tomotaka Kato, Hiroaki Ono, Mikiya Fujii
|Apr 12, 2021
Prediction of early recurrence of pancreatic ductal adenocarcinoma after resection.Toshitaka Sugawara, Daisuke Ban, Jo Nishino
Pageof 1
Frequent Collaborators
3 joint publications
Daisuke Ban
3 joint publications
Shinji Tanaka
2 joint publications
Shu Shimada
1 joint publications
Toshitaka Sugawara
1 joint publications
Kentaro Umemura
1 joint publications
Yoshimitsu Akiyama
1 joint publications
Megumi Hatano
1 joint publications
Ayumi Kono
1 joint publications
Koya Yasukawa
1 joint publications
Atsushi Kamachi
